FDA gives drugmakers 3 weeks to begin reporting supply chain data

Regulatory NewsRegulatory NewsAdvanced therapies/cell and gene therapyAPIsBiologics/ biosimilars/ vaccinesCombination products/companion diagnosticsGenericsNorth AmericaOTCPharmaceuticalsRegulatory Intelligence/PolicyUnited States